HPV16 E7 siRNA (hpv) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemHPV16 E7 siRNA (hpv)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-270423
Quantity10 µM
Specieshuman
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancerVirol JMarch 5, 2026Mahaiwon Shadang, Aruna Arumugam, Dhiraj Kumar Singh, Pankaj Keshari, Sandeep Mathur, Venkateswaran K. Iyer, Seema Singhal, Shyam S. Chauhan, Qulsum Akhter, Riyaz Ahmad Mirused in this study were NOP17 siRNA(h) (Santa Cruz, sc-97385) and HPV16 E7 siRNA (hpv) (Santa Cruz, sc-270423). Western blotting After electrophoresis with SDS-PAGE, the separated proteins were transferred onto

(2) cIAP-2 protein is upregulated by human papillomavirus in oropharyngeal cancers: role in radioresistance in vitroInfectious Agents and CancerSeptember 27, 2024Carolina Oliva, Diego Carrillo-Beltrán, Julio C. Osorio, Iván Gallegos, Felipe Carvajal, Claudio Mancilla-Miranda, Paul Boettiger, Enrique Boccardo, Francisco Aguayoand cIAP2 was performed in SCC-143 E6/E7 cells using small interfering RNA (siRNA) (SC-156008 for E6, SC-270423 for E7, SC-29850, Santa Cruz). A scramble sequence was used as the negative control (SC-37007, Santa Cruz

(3) HPV16E1 downregulation altered the cell characteristics involved in cervical cancer developmentScientific ReportsOctober 25, 2023Thanayod Sasivimolrattana, Arkom Chaiwongkot, Parvapan Bhattarakosolwere transfected with either HPV16E6 siRNA (sc-156008; Santa Cruz Biotechnology, USA), HPV16E7 siRNA (sc-270423; Santa Cruz Biotechnology, USA), HPV16E6 + E7 siRNA, or NTC to a final concentration of 5 pmol/well

(4) Exploitation of ATP-sensitive potassium ion (K(ATP)) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signallingOncogeneAugust 1, 2023Scarth JA, Wasson CW, Patterson MR, Evans D, Barba-Moreno D, Carden H, Cassidy R, Whitehouse A, Mankouri J, Samson A, et al.(FlexiTube GeneSolution GS3767) were purchased from Qiagen. HPV16 E6 siRNA (sc-156008) and HPV16 E7 siRNA (sc-270423) were purchased from Santa Cruz Biotechnology (SCBT). HPV18 E6 siRNAs were purchased from Dharmacon

(5) HIV-1 Proteins gp120 and Tat Promote Epithelial-Mesenchymal Transition and Invasiveness of HPV-Positive and HPV-Negative Neoplastic Genital and Oral Epithelial CellsMicrobiology spectrumDecember 21, 2022Lien K, Mayer W, Herrera R, Padilla NT, Cai X, Lin V, Pholcharoenchit R, Palefsky J, Tugizov SM.(Leica). Transfection of AKC-2 cells with siRNAs. The siRNAs targeting HPV-16 E6 (sc-156008) and HPV-16 E7 (sc-270423) were purchased from Santa Cruz Biotechnology; nonspecific siRNA-A (sc-37007) was used as a negative

(6) Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancerPloS oneJanuary 1, 2022D S P, Chaturvedi PK, Krishnamoorthy D, Seo YS, Thippana M, Park WY.control groups were treated with scrambled siRNA (HPV16 E6: cat. no. sc-156008; HPV16 E7: cat. no. sc-270423; control siRNA cat. no. sc-37007; Santa Cruz). Briefly, cells were grown overnight in an antibiotic-free

(7) Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cellsOncology reportsNovember 1, 2019Aedo-Aguilera V, Carrillo-Beltrán D, Calaf GM, Muñoz JP, Guerrero N, Osorio JC, Tapia JC, León O, Contreras HR, Aguayo F.RNA (siRNA) targeting PIR (cat. no. sc‑61359; Santa Cruz Biotechnology, Inc.), HPV16 E6/E7 (cat. no. sc‑270423; Santa Cruz Biotechnology, Inc.) and Silencer™ Select Negative Control No. 1 siRNA (cat. no. 4390843;

(8) E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell lineThe Journal of general virologyMay 1, 2018Wechsler EI, Tugizov S, Herrera R, Da Costa M, Palefsky JM.

(9) Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerCancer researchMay 1, 2018Brand TM, Hartmann S, Bhola NE, Li H, Zeng Y, O'Keefe RA, Ranall MV, Bandyopadhyay S, Soucheray M, Krogan NJ, et al.were transiently transfected with siRNAs targeting E6 and E7 (Santa Cruz Biotechnology, sc-156008 and sc-270423), HER3 siRNA (ON-TARGETplus, SMARTpool #L-003127; GE Dharmacon) or nontargeting siRNA (siNT; ON-TARGETplus

(10) Human papillomavirus E7 induces p63 expression to modulate DNA damage responseCell death & diseaseJanuary 26, 2018Eldakhakhny S, Zhou Q, Crosbie EJ, Sayan BS.#217143, #115454) (Paisley, UK), targeting HPV-16 E6 and HPV-16 E7 were from Santa Cruz (sc-156008 and sc-270423) (Santa Cruz Inc.). Scrambled control siRNA was from Qiagen (#1027310) (QIAGEN Ltd., Manchester, UK).

(11) HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cellsTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJuly 1, 2017Shao JS, Sun J, Wang S, Chung K, Du JT, Wang J, Qiu XS, Wang EH, Wu GP.(qRT-PCR). Small-interfering RNA HPV16 E6 small-interfering RNA (SiRNA; sc-156008), HPV16 E7 SiRNA (sc-270423), LKB1 SiRNA (sc-35816), and Control SiRNA (sc-37007) were purchased from Santa Cruz Biotechnology (Santa

(12) Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV(+) PatientsClinical cancer research : an official journal of the American Association for Cancer ResearchJune 15, 2017Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, Isaacson Wechsler E, Ranall MV, Bandyopadhyay S, Duvvuri U, et al.Dharmacon). siRNAs targeting E6 and E7 were purchased from Santa Cruz Biotechnology, sc-156008 and sc-270423. Lipofectamine RNAiMAX was used for all siRNA experiments according to the manufacturer’s instructions

(13) DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in miceJournal of virological methodsSeptember 1, 2014Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H.

Be the First to Write a Review!